Invesco Biotechnology & Genome ETF PBE
102.34 USD +1.21 (+1.20%)
Nov 3, 2026, 3:59 PM EST
102.34 Day range 103.15
73.16 52-week range 104.24
- YTD
- +24.58%
- 1 year
- +37.02%
- Market cap
- 307.51M
- EPS (ttm)
- 3.66
- P/E ratio
- 27.94
- YTD return
- +24.58%
- 1-year return
- +37.02%
- Volume
- 15.78K
- Avg volume
- 20.01K
- Open
- 101.27
- Previous close
- 101.13
- Day's range
- 102.34 – 103.15
- 52-week range
- 73.16 – 104.24
2Y +33.66 (+49.01%)
Key statistics
- Enterprise value
- 0
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Short % of float
- 0.00%
- 50-day average
- 69.17
- 200-day average
- 67.04
About Invesco Biotechnology & Genome ETF
The fund generally will invest at least 90% of its total assets in securities that comprise the underlying index. The underlying index was composed of common stocks of U.S. biotechnology and genome companies. These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc. It is non-diversified.
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on PBE — it syncs with the Stock Master app.